Book contents
- Leong’s Manual of Diagnostic Biomarkers for Immunohistology
- Leong’s Manual of Diagnostic Biomarkers for Immunohistology
- Copyright page
- Dedication
- Contents
- Contributors
- Preface
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Plate Section (PDF Only)
- References
Dictionary
Published online by Cambridge University Press: 03 July 2022
Book contents
- Leong’s Manual of Diagnostic Biomarkers for Immunohistology
- Leong’s Manual of Diagnostic Biomarkers for Immunohistology
- Copyright page
- Dedication
- Contents
- Contributors
- Preface
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Dictionary
- Plate Section (PDF Only)
- References
- Type
- Chapter
- Information
- Leong's Manual of Diagnostic Biomarkers for Immunohistology , pp. 303 - 354Publisher: Cambridge University PressPrint publication year: 2022
References
Selected references
Flavell, DJ, Jones, DB, Wright, DH. Identification of tissue histiocytes on paraffin sections by a new monoclonal antibody. J Histochem Cytochem 1987;35:1217–26.Google Scholar
Selected references
Busam, KJ, Jungbluth, AA. Melan-A, a new melanocytic differentiation marker. Adv Anat Pathol 1999;6:182–7.Google Scholar
Selected references
Lele, SM, Graves, K, Gatalica, Z. Immunohistochemical detection of maspin is a useful adjunct in distinguishing radial sclerosing lesion from tubular carcinoma of the breast. Appl Immunohistochem Mol Morphol 2000;8:32–6.Google Scholar
Selected references
Gelsleichter, L, Gown, AM, Zarbo, RJ, et al. P53 and mdm-2 expression in malignant melanoma: An immunocytochemical study of expression of p53, mdm-2, and markers of cell proliferation in primary versus metastatic tumors. Mod Pathol 1995;8:530–5.Google ScholarPubMed
Clay, MR, Martinez, AP, Weiss, SW, et al.MDM2 and CDK4 immunohistochemistry: Should it be used in problematic differentiated lipomatous tumors? Am J Surg Pathol 2016;40:1647–52.Google Scholar
Selected references
Allen, IV, McQuaid, S, McMahon, J, et al. The significance of measles virus antigen and genome distribution in the CNS in SSPE for mechanisms of viral spread and demyelination. J Neuropathol Exp Neurol 1996;55:471–80.Google Scholar
Selected references
Albelda, SM, Muller, WA, Buck, CA, et al. Molecular and cellular properties of PECAM-1 (endoCAM/CD31): A novel vascular cell-cell adhesion molecule. J Cell Biol 1991;114:1059–68.Google Scholar
Kuzu, I, Bicknell, R, Fletcher, CDM, et al. Expression of adhesion molecules on the endothelium of normal tissue vessels and vascular tumors. Lab Invest 1993;69:322–8.Google Scholar
Selected references
Chang, K, Pastan, I. Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers. Proc Natl Acad Sci USA 1996;93:136–40.Google Scholar
Ordóñez, NG. Value of mesothelin immunostaining in the diagnosis of mesothelioma. Mod Pathol 2003;16:192–7.Google Scholar
Selected references
Jasani, B, Schmid, KW. Significance of metallothionein overexpression in human tumors. Histopathology 1997;31:211–14.Google Scholar
Kagi, JHR. Overview of metallothionein: Metallobiochemistry Part B: metallothionein and related molecules. Meth Enzymol 1993;205:613–26.Google Scholar
Selected references
Busam, KJ, Iversen, K, Copian, KC, et al. Analysis of microphthalmia transcription factor expression in normal tissues and tumors, and comparison of its expression with S-100 protein, gp100, and tyrosinase in desmoplastic malignant melanoma. Am J Surg Pathol 2001;25:197–204.Google Scholar
Selected references
Lanza, G, Gafa, R, Maestri, I, et al. Immunohistochemical pattern of MLH1/MSH2 expression is related to clinical and pathological features in colorectal adenocarcinomas with microsatellite instability. Mod Pathol 2002; 15: 741–9.Google Scholar
Selected references
Edwards, C, Oates, J. OV 632 and MOC 31 in the diagnosis of mesothelioma and adenocarcinoma: An assessment of their use in formalin fixed and paraffin wax embedded material. J Clin Pathol 1995;48:626–30.Google Scholar
Selected references
Bedeir, A, Krasinskas, AM. Molecular diagnostics of colorectal cancer. Arch Pathol Lab Med 2011;135(5):578–87.Google Scholar
Bellizzi, AM, Frankel, WL. Colorectal cancer due to deficiency in DNA mismatch repair function: A review. Adv Anat Pathol 2009;16(6):405–17.Google Scholar
Garg, K, Leitao, MM Jr, Kauff, ND, et al. Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities. Am J Surg Pathol 2009;33(6):925–33.CrossRefGoogle ScholarPubMed
Hall, G, Clarkson, A, Shi, A, et al. Immunohistochemistry for PMS2 and MSH6 can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma. Pathology 2010;42(5):409–13.CrossRefGoogle ScholarPubMed
Klarskov, L, Holck, S, Bernstein, I, et al. Challenges in the identification of MSH6-associated colorectal cancer: Rectal location, less typical histology, and a subset with retained mismatch repair function. Am J Surg Pathol 2011;35(9):1391–9.Google Scholar
Radu, OM, Nikiforova, MN, Farkas, LM, et al. Challenging cases encountered in colorectal cancer screening for Lynch syndrome reveal novel findings: Nucleolar MSH6 staining and impact of prior chemoradiation therapy. Hum Pathol 2011;42(9):1247–58.Google Scholar
Shia, JR, Tang, LH, Vakiani, E, et al. Immunohistochemistry as first-line screening for detecting colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: A 2-antibody panel may be as predictive as a 4-antibody panel. Am J Surg Pathol 2009;33(11):1639–45.Google Scholar
Selected references
Adsay, NV, Merati, K, Basturk, O, et al. Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: Delineation of an “intestinal” pathway of carcinogenesis in the pancreas. Am J Surg Pathol 2004;28(7): 839–48.CrossRefGoogle ScholarPubMed
Chu, PG., Schwarz, RE, Lau, SK, et al. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: Application of CDX2, CK17, MUC1, and MUC2. Am J Surg Pathol 2005;29(3): 359–67.CrossRefGoogle ScholarPubMed
Kuan, SF, Montag, AG, Hart, J, et al. Differential expression of mucin genes in mammary and extramammary Paget’s disease. Am J Surg Pathol 2001;25(12): 1469–77.Google Scholar
Lau, SK, Weiss, LM, Chu, PG. Differential expression of MUC1, MUC2, and MUC5AC in carcinomas of various sites. Am J Clin Pathol 2004;122(1): 61–9.Google Scholar
McIntire, MG, Soucy, G, Vaughan, TL, et al. MUC2 is a highly specific marker of goblet cell metaplasia in the distal esophagus and gastroesophageal junction. Am J Surg Pathol 2011;35(7): 1007–13.CrossRefGoogle ScholarPubMed
Rousseau, K, Byrne, C, Kim, YS, et al. The complete genomic organization of the human MUC6 and MUC2 mucin genes. Genomics 2004;83(5): 936–9.CrossRefGoogle ScholarPubMed
Selected references
Doyle, LA, Möller, E, Dal Cin, P, et al. MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma. Am J Surg Pathol 2011;35:733–41.CrossRefGoogle ScholarPubMed
Doyle, LA, Wang, WL, Dal Cin, P, et al. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: Association with FUS gene rearrangement. Am J Surg Pathol 2012;36:1444–51.Google Scholar
Matsuyama, A, Jotatsu, M, Uchihashi, K, et al. MUC4 expression in meningiomas: Under-recognized immunophenotype particularly in meningothelial and angiomatous subtypes. Histopathology 2019;74:276–83.Google Scholar
Selected references
Brown, IS, Whiteman, DC, Lauwers, GY. Foveolar type dysplasia in Barrett esophagus. Mod Pathol 2010;23(6):834–43.Google Scholar
Handra-Luca, A, Lamas, G, Bertrand, J-C, et al. MUC1, MUC2, MUC4, and MUC5AC expression in salivary gland mucoepidermoid carcinoma: Diagnostic and prognostic implications. Am J Surg Pathol 2005;29(7):881–9.Google Scholar
Kuan, SF, Montag, AG, Hart, J, et al. Differential expression of mucin genes in mammary and extramammary Paget’s disease. Am J Surg Pathol 2001;25(12):1469–77.Google Scholar
Lau, SK, Weiss, LM, Chu, PG. Differential expression of MUC1, MUC2, and MUC5AC in carcinomas of various sites. Am J Clin Pathol 2004;122(1):61–9.Google Scholar
O’Connell, FP, Wang, HH, Odze, RD. Utility of immunohistochemistry in distinguishing primary adenocarcinomas from metastatic breast carcinomas in the gastrointestinal tract. Arch Pathol Lab Med 2005;129(3):338–47.Google Scholar
Pinto-de-Sousa, J, David, L, Reis, CA, et al. Mucins MUC1, MUC2, MUC5AC and MUC6 expression in the evaluation of differentiation and clinico-biological behaviour of gastric carcinoma. Virchows Arch 2002. 440(3):304–10.CrossRefGoogle ScholarPubMed
Selected references
Adsay, V, Jang, K-T, Roa, JC, et al. Intracholecystic papillary-tubular neoplasms (ICPN) of the gallbladder (neoplastic polyps, adenomas, and papillary neoplasms that are ≥1.0 cm): Clinicopathologic and immunohistochemical analysis of 123 cases. Am J Surg Pathol 2012;36:1279–301.Google Scholar
Bartman, AE, Buisine, MP, Aubert, JP, et al. The MUC6 secretory mucin gene is expressed in a wide variety of epithelial tissues. J Pathol 1999;186:398–405.Google Scholar
Chu, PG, Chung, L, Weiss, LM, et al. Determining the site of origin of mucinous adenocarcinoma: An immunohistochemical study of 175 cases. Am J Surg Pathol 2011;35:1830–6.Google Scholar
Khor, TS, Alfaro, EE, Ooi, EMM, et al. Divergent expression of MUC5AC, MUC6, MUC2, CD10, and CDX-2 in dysplasia and intramucosal adenocarcinomas with intestinal and foveolar morphology: Is this evidence of distinct gastric and intestinal pathways to carcinogenesis in Barrett esophagus? Am J Surg Pathol 2012;36:331–42.CrossRefGoogle ScholarPubMed
Kosmahl, M, Wagner, J, Peters, K, et al. Serous cystic neoplasms of the pancreas: An immunohistochemical analysis revealing alpha-inhibin, neuron-specific enolase, and MUC6 as new markers. Am J Surg Pathol 2004 28:339–46.CrossRefGoogle ScholarPubMed
Selected references
Falini, B, Fizzotti, M, Pucciarini, A, et al. A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells. Blood 2000; 95(6):2084–92.Google Scholar
Gualco, G, Weiss, LM, Bacchi, CE. MUM1/IRF4: A review. Appl Immunohistochem Mol Morphol 2010; 18:301–10.CrossRefGoogle ScholarPubMed
Klein, U, Casola, S, Cattoretti, G, et al. Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination. Nat Immunol 2006;7:773–82.CrossRefGoogle ScholarPubMed
Shaffer, AL, Emre, NC, Lamy, L, et al. IRF4 addiction in multiple myeloma. Nature 2008;454:226–31.Google Scholar
Selected references
Azumi, N, Ben-Erza, J, Battifora, H. Immunophenotypic diagnosis of leiomyosarcomas and rhabdomyosarcomas with monoclonal antibodies to muscle specific actin and desmin in formalin-fixed tissue. Mod Pathol 1988;1:469–74.Google ScholarPubMed
Selected references
Carabias, E, Palenque, E, Serrano, R, et al. Evaluation of an immunohistochemical test with polyclonal antibodies raised against mycobacteria used in formalin-fixed tissue compared with mycobacterial specific culture. APMIS 1998;106:385–8.CrossRefGoogle ScholarPubMed
Selected references
Clark, HB, Minesky, JJ, Agrawal, D, et al. Myelin basic protein and P2 protein are not immunohistochemical markers for Schwann cell neoplasms: A comparative study using antisera to S100, P2, and myelin basic proteins. Am J Pathol 1985;121:96–101.Google Scholar
Selected references
Mason, DY, Taylor, CR. The distribution of muramidase (lysozyme) in human tissues. J Clin Pathol 1975;28:124–32.CrossRefGoogle ScholarPubMed
Pinkus, GS, Pinkus, JL. Myeloperoxidase: A specific marker for myeloid cells in paraffin sections. Mod Pathol 1991;4:733–41.Google Scholar
Selected references
Cessna, MH, Zhou, H, Perkins, SL, et al. Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics. Am J Surg Pathol 2001;25:1150–7.CrossRefGoogle ScholarPubMed
Wesche, WA, Fletcher, CDM, Dias, E, et al. Immunohistochemistry of MyoD1 in adult pleomorphic soft tissue sarcomas. Am J Surg Pathol 1995;19:261–9.CrossRefGoogle ScholarPubMed
Selected references
Cessna, M, Zhou, H, Perkins, S, et al. Are myogenin and MyoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics. Am J Surg Pathol 2020;99:75–79. doi:10.1016/j.humpath.2020.03.006.Google Scholar
Flope, AL. MyoD1 and myogenin expression in human neoplasia: A review and update. Adv Anat Pathol 2002;9:198–203.Google Scholar
Olson, NJ, Fritchie, KJ, Torres-Mora, J, et al. MyoD1 expression in fibroepithelial stromal polyps. Hum Pathol 2020;99:75–79. doi: 10.1016/j.humpath.2020.03.006. Epub 2020 Mar 23.Google Scholar
Selected references
Kunishige, M, Mitsui, T, Akaike, M, et al. Localisation and amount of myoglobin and myoglobin mRNA in ragged-red fiber of patients with mitochondrial encephalomyopathy. Muscle Nerve 1996;19:175–82.3.0.CO;2-B>CrossRefGoogle ScholarPubMed
Zhang, JM, Piddick, L. Cytoskeleton immunohistochemical study of early ischemic myocardium. Forensic Sci Int 1996;80:229–38.CrossRefGoogle ScholarPubMed